Iran launched missiles at US Navy destroyers, prompting retaliatory strikes on Iranian targets amid a fragile ceasefire. The US and Iran exchanged military strikes in the Strait of Hormuz, marking the most severe breach of their month-long ceasefire. Iranian forces targete
The company reported Q1 2026 revenue of $5.3 million, with $2.5 million from recurring sources and $2.9 million from capital equipment sales. Profound Medical Corp. projected approximately $25 million in revenue for 2026 during its Q1 2026 earnings call. The company report
Authorities intervened during thin holiday markets, adding to $35 billion spent on April 30 to support the yen. Japan intervened in currency markets during early May holidays, spending up to JPY5 trillion or $32 billion between May 1 and May 6. The move followed a $35 bill
The industrial technology firm projects $12M-$15M in CapEx for fiscal 2026 as it advances its Dothan facility transition. Allient Inc. outlined a $12M-$15M capital expenditure plan for fiscal 2026, aiming to complete its Dothan facility transition by the end of Q3. The com
Phibro Animal Health raises full-year guidance after Q3 net sales rose 10% to $383 million and adjusted EBITDA climbed 11% to $60 million. Phibro Animal Health Corporation updated its fiscal 2026 guidance, projecting net sales between $1.46 billion and $1.5 billion. Adjust
The company reported Q1 2026 production growth of 6% year-over-year, exceeding its 2026 guidance midpoint. Magnolia Oil & Gas announced plans to achieve approximately 5% production growth in 2026, supported by $155M in bolt-on acquisitions. The company’s Q1 2026 output ros
Arrowhead Pharmaceuticals targets Q3 topline data for SHASTA-3/4 and a supplemental NDA submission by year-end 2026. Arrowhead Pharmaceuticals announced plans to release topline data for its SHASTA-3/4 programs in Q3 2026. The company also aims to file a supplemental new d
Japan intervened in forex markets, spending $67 billion Japan intervened in forex markets during early May holidays and on April 30, spending around $67 billion to support the yen. The intervention was deliberately timed to coincide with the holiday period when market
The biotech firm raises its outlook after Q1 2026 progress in partner milestones boosts revenue visibility. OmniAb Inc. (OABI) expects 2026 revenue between $28M and $33M, driven by advancements in partner programs. The updated forecast reflects stronger pipeline visibility
The eyewear retailer reported Q1 2026 revenue of $242 million, up 8.3% year-over-year, with adjusted EBITDA at $30 million. Warby Parker projected 2026 revenue between $959 million and $976 million, aligning with its strategic push into AI-powered glasses later this year.
ادخل بحساب جوجل لمشاركة رأيك والتفاعل مع الأخبار — بلا كلمة مرور.
إيميلك يبقى موثّقاً وخصوصيتك محفوظة.